Advanced Medical Solutions Group’s (AMS) “Buy” Rating Reaffirmed at Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a report released on Wednesday morning, MarketBeat reports. They currently have a GBX 300 ($3.96) price objective on the stock.

Advanced Medical Solutions Group Trading Down 8.2 %

AMS stock opened at GBX 225 ($2.97) on Wednesday. The firm’s fifty day simple moving average is GBX 240.06 and its two-hundred day simple moving average is GBX 216.34. The company has a quick ratio of 4.58, a current ratio of 5.67 and a debt-to-equity ratio of 3.74. The stock has a market capitalization of £482.58 million, a price-to-earnings ratio of 4,500.00, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a twelve month low of GBX 171.60 ($2.27) and a twelve month high of GBX 275.83 ($3.64).

Advanced Medical Solutions Group Cuts Dividend

The business also recently declared a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 26th will be paid a GBX 0.77 ($0.01) dividend. This represents a yield of 0.32%. The ex-dividend date of this dividend is Thursday, September 26th. Advanced Medical Solutions Group’s dividend payout ratio is presently 4,000.00%.

Advanced Medical Solutions Group Company Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.